Skip to content

The European Medical Device Directive (MDD)

    The Medical Device Directive (MDD) was a regulatory framework established by the European Union to ensure the safety and performance of medical devices. It aimed to harmonize the laws related to medical devices within the EU, allowing for the free movement of these products across member states. The MDD has been replaced by the Medical Device Regulation (MDR), which was fully applied on May 26, 2021.

    Purpose & Scope of MDD

    The MDD was designed to ensure that medical devices marketed in the EU were safe and effective for their intended purposes.

    The MDD was applied to various medical devices, ranging from simple bandages to complex machinery like pacemakers.

    Timeline of the EU MDD

    • Early 1980s: The European Commission recognized the need for harmonized regulations for medical devices to facilitate trade and ensure high safety and quality standards across member states.
    • Mid-1980s: Initial discussions and consultations with stakeholders, including industry representatives, healthcare professionals, and member state authorities, led to the drafting of a directive.
    • 1990: The first proposal for the Medical Device Directive was introduced by the European Commission.
    • June 14, 1993: The Council of the European Communities formally adopted Directive 93/42/EEC, known as the Medical Device Directive (MDD). It was published in the Official Journal of the European Communities on July 12, 1993.
    • 2012: The European Commission proposed new regulations to replace the MDD and the Active Implantable Medical Devices Directive (AIMDD) due to the need for stricter controls and better regulatory frameworks.
    • April 5, 2017: The European Parliament and the Council adopted the Medical Device Regulation (MDR) (Regulation (EU) 2017/745).
    • May 26, 2017: The MDR entered into force, initiating a three-year transition period for manufacturers to comply with the new requirements.
    • May 26, 2021: The MDR became fully applicable, replacing the MDD and AIMDD.

    Key Requirements of the Medical Device Directive

    Safety and Performance Documentation

    Manufacturers were required to ensure that their medical devices were safe and performed effectively. This involved creating comprehensive technical documentation, which included:

    • Design and Manufacturing Records: Detailed documentation of the design and manufacturing processes.
    • Risk Analysis: Identification and assessment of potential risks associated with the device.
    • Clinical Data: Collection and analysis of clinical data, both pre-market and post-market.

    Device Classification

    Medical devices were classified based on risk, with four classes:

    • Class I: Low risk
    • Class IIa: Medium risk
    • Class IIb: Higher risk
    • Class III: Highest risk

    CE Marking

    To market a device in the EU, manufacturers had to affix the CE marking, indicating compliance with the MDD. This involved:

    1. Determining device classification.
    2. Establishing a Quality Management System.
    3. Preparing technical documentation.
    4. Conducting a clinical evaluation.
    5. Engaging a Notified Body (if required).
    6. Performing a conformity assessment.
    7. Preparing and implementing a Unique Device Identification (UDI) system.
    8. Compiling a declaration of conformity.
    9. Affixing the CE marking.
    10. Registering the device and manufacturer.

    Required Documentation for CE Marking

    • Device description and specifications.
    • Design and manufacturing information.
    • Risk management and risk analysis.
    • Clinical evaluation reports (CERs).
    • Preclinical and clinical data.
    • Post-market surveillance plan.

    Transition from MDD to MDR

    Manufacturers needed to update documentation and processes to comply with the MDR. This included:

    • Technical File: Ensure all aspects, including device description, design, and manufacturing information, comply with MDR.
    • Clinical Data: Update clinical data and evaluation reports.
    • Risk Management: Ensure risk management processes meet MDR standards.
    • PMS Plan: Develop a comprehensive post-market surveillance plan.
    • Vigilance Reporting: Implement processes for timely reporting of adverse events.
    • Periodic Safety Update Report (PSUR): Prepare PSURs for Class IIa, IIb, and III devices.

    Additional Resources and Further Reading

    1. European Commission – Medical Devices: Provides updates, guidance documents, and information on MDR.
    2. EUDAMED (European Database on Medical Devices): Offers access to information on medical devices available on the EU market and related regulatory updates.
    3. Medical Device Coordination Group (MDCG) Guidance: Issues guidance documents and advice on implementing MDR.
    4. BSI Group: BSI Medical Devices: Provides information on certification and regulatory compliance for medical devices.
    5. TÜV SÜD: TÜV SÜD Medical Devices: Offers comprehensive testing and certification services for medical devices and in vitro diagnostics.
    Back To Top